Submitting a variation that impacts the SmPC, label and Patient Information Leaflet (PIL)
![](https://medregs.blog.gov.uk/wp-content/uploads/sites/195/2018/06/advise-arrow-billboard-208494-620x453.jpg)
Several variations have a direct or consequential impact on the product information of a Marketing Authorisation (MA), by introducing changes to the SmPC and fragments, labelling and Patient Information Leaflets (PILs); these variations have a range of submission requirements …